Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Retained Earnings: 2013-2025

Historic Retained Earnings for Fortress Biotech (FBIO) over the last 13 years, with Sep 2025 value amounting to -$730.1 million.

  • Fortress Biotech's Retained Earnings rose 0.54% to -$730.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$730.1 million, marking a year-over-year increase of 0.54%. This contributed to the annual value of -$740.9 million for FY2024, which is 6.62% down from last year.
  • Fortress Biotech's Retained Earnings amounted to -$730.1 million in Q3 2025, which was up 0.79% from -$736.0 million recorded in Q2 2025.
  • In the past 5 years, Fortress Biotech's Retained Earnings ranged from a high of -$491.6 million in Q1 2021 and a low of -$751.5 million during Q1 2025.
  • Moreover, its 3-year median value for Retained Earnings was -$721.2 million (2024), whereas its average is -$712.8 million.
  • As far as peak fluctuations go, Fortress Biotech's Retained Earnings dropped by 18.07% in 2022, and later rose by 0.54% in 2025.
  • Quarterly analysis of 5 years shows Fortress Biotech's Retained Earnings stood at -$547.5 million in 2021, then declined by 15.85% to -$634.2 million in 2022, then dropped by 9.56% to -$694.9 million in 2023, then decreased by 6.62% to -$740.9 million in 2024, then rose by 0.54% to -$730.1 million in 2025.
  • Its last three reported values are -$730.1 million in Q3 2025, -$736.0 million for Q2 2025, and -$751.5 million during Q1 2025.